S1039 Onset of the COVID-19 Pandemic Did Not Negatively Impact Adherence to Vedolizumab Among IBD Patients

Introduction: The onset of the COVID-19 pandemic caused numerous disruptions in patient care; however, per expert opinion and early guidance from national GI societies IBD patients were encouraged to continue biologic therapy. Comparisons were made between 2019 (reference period) and the two PPs usi...

Full description

Saved in:

Bibliographic Details
Published in:	The American journal of gastroenterology Vol. 118; no. 10S; pp. S788 - S789
Main Authors:	Christopher, Lindholm, Nemer, Mary, Fass, Lucas, Osman, Fauzia, Caldera, Freddy, Saha, Sumona
Format:	Journal Article
Language:	English
Published:	New York Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01-10-2023
Subjects:	COVID-19 Hospitalization Pandemics Patients Steroids
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Introduction: The onset of the COVID-19 pandemic caused numerous disruptions in patient care; however, per expert opinion and early guidance from national GI societies IBD patients were encouraged to continue biologic therapy. Comparisons were made between 2019 (reference period) and the two PPs using chi-squared or Fisher’s exact tests. Comparisons between groups and continuous data were done using ANOVA or non-parametric Wilcoxon sign rank tests.
ISSN:	0002-9270 1572-0241
DOI:	10.14309/01.ajg.0000953796.48742.f7